Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CVTX
日付受信時刻ニュースソース見出しコード企業名
2009/04/1806 : 01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1805 : 32Edgar (US Regulatory)(25-NSE)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1805 : 15Business WireGilead Sciences Completes Acquisition of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1706 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1706 : 00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1604 : 54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1419 : 09Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1419 : 06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1406 : 23Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1406 : 09Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1004 : 11Edgar (US Regulatory)Schedule 13GNASDAQ:CVTXCV Therapeutics (MM)
2009/04/0904 : 27Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/0823 : 49MarketwiredAnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIPNASDAQ:CVTXCV Therapeutics (MM)
2009/04/0708 : 50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/0705 : 12Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/0703 : 02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:CVTX